中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 11
Nov.  2013
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2013  >  29(11): 844-847

Therapeutic effect of autologous bone marrow stem cell transplantation through portal vein or hepatic artery in treatment of decompensated liver cirrhosis: a comparative study

DOI: 10.3969/j.issn.1001-5256.2013.11.011

  • Department of Infectious Diseases, Anning Branch of General Hospital of Lanzhou Military Area Command

  • Received Date: 2013-02-08
  • Published Date: 2013-11-20
    Abstract
  • Objective To conduct a comparative study on the therapeutic effect and safety of autologous bone marrow stem cell transplantation through the portal vein or hepatic artery in the treatment of decompensated liver cirrhosis. Methods A retrospective analysis was performed on the clinical data of 50 patients with decompensated liver cirrhosis who were hospitalized from December 2006 to May 2012. In addition to basic treatment, 25 of these patients underwent ultrasound- guided percutaneous liver puncture and autologous bone marrow stem cell transplantation through the portal vein ( portal vein group) , and the rest underwent radiology- guided femoral artery catheterization and autologous bone marrow stem cell transplantation through the proper hepatic artery ( hepatic artery group) . There were no significant differences in baseline conditions between the two groups. At 2, 4, and 8 weeks after operation, alanine aminotransferase ( ALT) , aspartate aminotransferase ( AST) , total bilirubin ( TBil) , and albumin ( Alb) levels and prothrombin time activity ( PTA) were measured, and improvements in symptoms and adverse events were evaluated.Comparisons between the two groups were made by independent- samples t test; comparisons between values before and after treatment were made by paired t test; categorical data were analyzed by chi- square test. Results Twenty- two cases ( 88. 0%) of the portal vein group showed significant improvements in fatigue and poor appetite, versus 21 cases ( 84. 0%) of the hepatic artery group ( P > 0. 05) . At 8 weeks after operation, the portal vein group and hepatic artery group had serum Alb levels of 34. 4 ± 7. 8 g / L and 33. 8 ± 8. 0 g / L, significantly higher than the values before operation ( 27. 1 ± 8. 9 g / L and 26. 8 ± 9. 6 g / L) ( P < 0. 05 for both) , but there was no significant difference between the two groups ( P > 0. 05) ;the two groups had PTAs of 58. 0% ± 13. 1% and 56. 9% ± 12. 8%, significantly higher than the values before operation ( 45. 5% ± 12. 3%and 47. 0% ± 11. 6%) ( P < 0. 05 for both) , but there was no significant difference between the two groups ( P > 0. 05) . The treatment led to no significant changes in ALT, AST, and TBil levels in either group ( P > 0. 05 for all) . The portal vein group and hepatic artery group had alpha- fetoprotein levels of 10. 3 ± 5. 9 ng / ml and 8. 9 ± 4. 3 ng / ml at 8 weeks after operation, without significant difference between the two groups ( P >0.05) . No severe adverse reactions or complications occurred in either group. Conclusion Autologous bone marrow stem cell transplantation through the portal vein or hepatic artery is safe and effective in the treatment of decompensated liver cirrhosis, and there is no significant difference in therapeutic effect between the two procedures.

     

    • FullText(HTML)
  • loading
    • References(1)
  • [1]XU Y, XUE BY.Study on integrated traditional Chinese and Western medicine therapy in treatment of hepatitis B cirrhosis[J].Jilin J Tradit Chin Med, 2011, 31 (12) :1180-1181. (in Chinese) 许岩, 薛博瑜.中西医治疗乙型肝炎肝硬化研究[J].吉林中医药, 2011, 31 (12) :1180-1181.[2]TERAI S, SAKAIDA I, YAMAMOTO N, et al.An uncomfortable silenceem leader while we all search for a better reporter gene in adult stem cell biology[J].Hepatology, 2004, 39 (4) :1143-1146.[3]LAGASSE E, CONNORS H, ALDHALIMY M, et al.Purified hematopoietic stem cells can differentiate into hepatocytes in vivo[J].Nat Med, 2000, 6 (11) :1229-1233.[4]YAO P, HU DR, WANG S, et al.Treatment of chronic hepatic failure with autologous bone marrow stem cells transplantation[J].Chin Hepatol, 2005, 10 (3) :171-173. (in Chinese) 姚鹏, 胡大荣, 王帅, 等.自体骨髓干细胞移植治疗慢性肝衰竭研究[J].肝脏, 2005, 10 (3) :171-173.[5]PAI M, ZACHAROULIS D, MILICEVIC MN, et al.Autologous infusion of expanded mobilized adult bone marrow-derived CD34+cells into patients with alcoholic liver cirrhosis[J].Am J Gastroenterol, 2008, 103 (8) :1952-1958.[6]LEVICAR N, PAI M, HABIB NA, et al.Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+cells in patients with chronic liver disease[J].Cell Prolif, 2008, 41 (1) :115-125.[7]TERAI S, ISHIKAWA T, OMORI K, et al.Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy[J].Stem Cells, 2006, 24 (10) :2292-2298.[8]MOHAMADNEJAD M, ALIMOGHADDAM K, MOHYEDDINBONAB M, et al.Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis[J].Arch Iran Med, 2007, 10 (4) :459-466.[9]KHAN AA, PARVEEN N, MAHABOOB VS, et al.Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure:a preliminary study[J].Transplant Proc, 2008, 40 (4) :1140-1144.[10]WANG F, ZHANG J, ZHOU XR, et al.The curative effect of automarrow stem cells transplantation through portal vein in treatment of 18patients with decompensated liver cirrhosis[J].J Clin Hepatol, 2011, 14 (3) :200-201. (in Chinese) 王方, 张静, 周新人, 等.经门静脉自体骨髓干细胞移植治疗失代偿期肝硬化18例疗效观察[J].实用肝脏病杂志, 2011, 14 (3) :200-201.[11]WANG F, ZHANG ZG, ZHANG J, et al.The curative effect of auto-marrow stem cells in treatment fo 50 patients with decompensated liver cirrhosis[J].J Clin Hepatol, 2010, 13 (4) :272-274. (in Chinese) 王方, 张小岗, 张静, 等.自体骨髓干细胞治疗失代偿期肝硬化患者50例疗效观察[J].实用肝脏病杂志, 2010, 13 (4) :272-274.[12]CHEN X, SUN GJ, ZHAO WJ, et al.Therapeutic efficacy of autologous bone marrow stem cells transplantation for treatment of terminal liver disease of 24 cases[J].J Clin Hepatol, 2012, 28 (1) :55-57. (in Chinese) 陈曦, 孙国军, 赵文静, 等.自体骨髓干细胞治疗终末期肝病24例临床观察[J].临床肝胆病杂志, 2012, 28 (1) :55-57.[13]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :IXVI. (in Chinese) 中华医学会肝病学分会, 感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :I-XVI.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2910) PDF downloads(594) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return